A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (Q28293805)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study |
scientific article |
Statements
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (English)
Appelbaum FR
1 reference
Weick JK
Kopecky KJ
Head DR
Kingsbury LL
Balcerzak SP
Bickers JN
Hynes HE
Welborn JL
Simon SR
1 October 1996
Identifiers
2 references